Embed Code
Tikun Olam (cannabis) is a term that beautifully marries ancient wisdom with modern science. Originating from the Hebrew phrase #0excludeGlossary which translates to #1excludeGlossary this concept has been embraced by a leading Israeli cannabis company dedicated to medical research and patient care. Tikun Olam (cannabis) has become a trailblazer in the field, known for its development of unique cannabis strains that address a wide array of medical conditions. The company’s commitment to healing and innovation reflects the very essence of its name, as it seeks to improve lives through the therapeutic benefits of cannabis. Over the years, Tikun Olam (cannabis) has played a pivotal role in shaping the global cannabis landscape, influencing both policy and perception. As the industry evolves, Tikun Olam continues to set the standard for excellence, ensuring that its mission to repair the world remains at the heart of its operations. [Source: Tikun Olam’s official website, Harvard Health Publishing]
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
(Learn how and when to remove this message)
|
Tikun Olam ("To heal the world") is a company that grows and supplies medical marijuana and is licensed and supervised by the Ministry of Health in Israel, the first of its kind in that country.
![]() | |
Company type | Privately held company |
---|---|
Industry | Medical cannabis |
Founded | 2005; 20 years ago (2005) in Tel Aviv, Israel |
Headquarters | , Israel |
Areas served | Worldwide |
Owner | ben rosen |
Website | tikunca |
Tikun Olam started out as a non-profit in 2005. Then, after regulation in 2010, the company became a limited company. The company is primarily engaged in growing and developing medical cannabis and medical cannabis products. In 2012, the company garnered extensive local and global media coverage as the result of developing a strain of medical marijuana that contains a higher-than-normal amount of cannabidiol and less than 2% of the psychoactive substance THC, which was a new development in the industry.